Page 5 - Urea Cycle Disorder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Urea cycle disorder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Urea Cycle Disorder Today - Breaking & Trending Today

Pheburane® (sodium phenylbutyrate) coverage to reach ~80%

PRINCETON, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) Medunik USA (member of Duchesnay Pharmaceutical Group, an international company selected in the. ....

New Jersey , United States , Tanya Carro , States Pheburane , Lucane Pharma , Duchesnay Pharmaceutical Group , Drug Administration , Medunik United States Inc , Global Hypergrowth Project , Medunik United States , California Contract Drug List , Duchesnay Pharmaceutical , Executive Vice President , Medunik United , Urea Cycle , Full Prescribing Information , Patient Information , Pharmaceutical Group , Analog Pharma , Global Hypergrowth , Urea Cycle Disorder , United States Pheburane , Medunik Usa ,

Genfit S.A. (NASDAQ:GNFT) Sees Large Decrease in Short Interest

Genfit S.A. (NASDAQ:GNFT – Get Free Report) was the target of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 114,300 shares, a drop of 8.1% from the September 15th total of 124,400 shares. Based on an average daily volume of 26,800 shares, the […] ....

Shaughnessy Asset Management , Citadel Advisors , Genfit Company Profile , Optiver Holding , Envestnet Asset Management Inc , Get Free Report , Asset Management , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily , Nasdaq Gnft ,

Equities Analysts Offer Predictions for Genfit S.A.'s FY2024 Earnings (NASDAQ:GNFT)

Equities Analysts Offer Predictions for Genfit S.A.'s FY2024 Earnings (NASDAQ:GNFT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Leerink Partnrs , Genfit Company Profile , Optiver Holding , Envestnet Asset Management Inc , Citadel Advisors , Shaughnessy Asset Management , Free Report , Asset Management , Get Free Report , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily ,

Genfit's (GNFT) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a research note released on Thursday morning, Benzinga reports. They currently have a $11.00 target price on the stock. Genfit Trading Down 0.6 % Shares of GNFT stock opened at $3.35 on Thursday. The company’s 50-day moving average price is […] ....

Citadel Advisors , Envestnet Asset Management Inc , Optiver Holding , Shaughnessy Asset Management , Free Report , Trading Down , Asset Management , Get Free Report , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily , Nasdaq Gnft , Reiterated Rating , Hc Wainwright ,

Genfit S.A. (NASDAQ:GNFT) Sees Large Drop in Short Interest

Genfit S.A. (NASDAQ:GNFT – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 104,000 shares, a decrease of 10.2% from the August 15th total of 115,800 shares. Currently, 0.2% of the shares of the company are short […] ....

Shaughnessy Asset Management , Optiver Holding , Genfit Company Profile , Citadel Advisors , Envestnet Asset Management Inc , Get Free Report , Asset Management , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily , Nasdaq Gnft ,